Skip to main content
Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.0110
-0.0007 (-6.14%)
At close: Dec 5, 2025

Petros Pharmaceuticals Revenue

Petros Pharmaceuticals had revenue of $5.11M in the twelve months ending September 30, 2025, down -1,503.44% year-over-year. In the year 2024, Petros Pharmaceuticals had annual revenue of $5.11M, down -12.20%.

Revenue
5.11M
Revenue Growth
-1,503.44%
P/S Ratio
0.09
Revenue / Employee
284.00K
Employees
18
Market Cap
466.10K

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20245.11M-710.35K-12.20%
Dec 31, 20235.82M-169.67K-2.83%
Dec 31, 20225.99M-1.82M-23.29%
Dec 31, 20217.81M-1.75M-18.29%
Dec 31, 20209.56M-6.02M-38.63%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Veradigm 588.02M
Elite Pharmaceuticals 122.89M
Glass House Brands 196.17M
American Oncology Network 1.76B
Northwest Biotherapeutics 937.00K
Silence Therapeutics 25.83M
Global Cord Blood 196.10M
Zomedica 29.45M
Revenue Rankings

Petros Pharmaceuticals News

More News